close
close

Lucinda Crabtree joins Oxford Biomedica today as Chief Financial Officer

Posted on by Vaseline
Lucinda Crabtree joins Oxford Biomedica today as Chief Financial Officer

Lucinda Crabtree joins Oxford Biomedica today as Chief Financial Officer

Oxford, UK – September 2, 2024: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica”, “OXB” or “the Company”), a quality and innovation-focused CDMO for cell and gene therapy, announces that Lucinda (Lucy) Crabtree Ph.D. has today joined Oxford Biomedica as Chief Financial Officer (CFO) and a Board Member. Lucinda’s appointment was previously announced on 17 July 2024.

Related Posts